Class II
Terminated
EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufactured by Paelra Pharmaceuticals. Inc., San Diego, California, USA
- Company
- Pacira Pharmaceuticals, Inc.
- Recall Initiated
- December 17, 2012
- Posted
- March 6, 2013
- Recall Number
- D-168-2013
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 324 vials
- Firm Location
- San Diego, CA, United States
Reason for Recall
Subpotent; bupivacaine
Distribution
Nationwide distribution: AZ, DC, FL, GA, MA, NJ, NY, OH, and TX.
Lot / Code Info
Lot #11-2005 Control #23542 Manufacture Date: 05Dec11 2011-L-009
More recalls by Pacira Pharmaceuticals, Inc.
Zilretta (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only,...
Jul 3, 2024 · Class II
Other recent Class II Drug recalls
Vista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, Dry Eye Relief, L...
Wizcure Pharmaa Private Limited
· Mar 4, 2026
Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: Av...
Avkare
· Mar 4, 2026
Agebox iKids-Growth (Day Formula) capsules, 60-count bottles, Manufactured Exclusively For: AGEBOX I...
Agebox
· Mar 4, 2026
Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPL...
Leo Pharma Inc
· Mar 4, 2026
Pro Numb Tattoo Numbing Spray, For Sensitive Skin, 4% Lidocaine, [1FL OZ/28.4 ML or 4 oz/120 mL] per...
Pro Numb Tattoo Numbing Spray Llc
· Feb 18, 2026